Nautilus Biotechnology, Inc. (NAUT) NASDAQ
2.68
-0.09(-3.25%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.68
-0.09(-3.25%)
Currency In USD
Address
2701 Eastlake Avenue East
Seattle, WA 98102
United States of America (the)
Phone
206 333 2001
Website
Sector
Healthcare
Industry
Biotechnology
Employees
134
First IPO Date
August 07, 2020
| Name | Title | Pay | Year Born |
| Sujal Patel | Co-Founder, Chief Executive Officer, President, Secretary & Director | 763,575 | 1975 |
| Subra Sankar | Senior Vice President of Product Development | 38,473 | 1960 |
| Kentaro Suzuki | Chief Marketing Officer | 143,435 | 1970 |
| Matthew Murphy ESQ. | General Counsel | 382,645 | 1965 |
| Gwen E. Weld | Chief People Officer | 390,968 | 1958 |
| Parag Mallick | Co-Founder, Chief Scientist & Director | 535,500 | 1978 |
| Anna Mowry | Chief Financial Officer & Treasurer | 551,200 | 1983 |
| Amber Faust | Vice President of Global Sales | 0 | N/A |
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.